AIM-AHEAD Consortium Information

The National Institutes of Health’s AIM-AHEAD program was established to create mutually beneficial and coordinated partnerships to empower researchers and communities across the United States in the development of AI/ML models and enhance the capabilities of this emerging technology, beginning with electronic health record (EHR) data. The rapid increase in the volume of data generated through electronic health records (EHRs) and other biomedical research presents exciting opportunities for developing data science approaches, such as AI/ML methods, to enhance biomedical research and improve healthcare. Several challenges hinder the widespread adoption of AI/ML technologies, including high costs, limited capability for broad application, and inadequate access to necessary infrastructure, resources, and training. Additionally, there is a lack of comprehensive and high-quality AI-ready data, as well as a shortage of a pipeline of talented researchers in both industry and academia, to harness the potential of AI/ML in advancing biomedical research and the practice of medicine. Furthermore, tackling the complex drivers of health outcomes require an innovative and transdisciplinary framework that transcends scientific and organizational silos. Mutually beneficial and trusted partnerships can be established to empower researchers and communities across the United States in AI/ML application.